Related Experiment Videos
Selective pressure by antibiotic use in livestock
1Robert Koch Institute, Wernigerode Branch, Burgstrasse 37, D-38855 Wernigerode, Germany. wittew@rki.de
International Journal of Antimicrobial Agents
|January 4, 2001
Summary
Antibiotic use in animal feed creates transferable resistance reservoirs. Banning these growth promoters in the EU has led to a decline in resistant bacteria, supporting their removal to protect human health.
Area of Science:
- Microbiology
- Veterinary Medicine
- Public Health
Background:
- Antibiotics used as growth promoters in food animals exert selective pressure, fostering reservoirs of transferable antibiotic resistance.
- This resistance has been observed for various antibiotics, including oxytetracycline, streptothricin, and glycopeptides, with documented transfer to human pathogens.
Purpose of the Study:
- To investigate the link between antibiotic use in animal husbandry and the emergence of transferable antibiotic resistance in bacterial populations.
- To assess the impact of specific antibiotic resistance genes and their dissemination pathways from animals to humans.
Main Methods:
- Review of existing studies on antibiotic resistance in food animals and human pathogens.
- Analysis of resistance determinants (e.g., sat genes, vanA gene cluster, vatA, vatG) and their genetic elements (e.g., plasmids).
- Correlation of antibiotic usage patterns with resistance trends in animal and human microbial communities.
Main Results:
- Transferable resistance determinants (sat, vanA) have been identified in animal ecosystems, linked to antibiotic use (nurseothricin, avoparcin).
- The vanA gene cluster in Enterococcus faecium, associated with avoparcin use, spreads to human flora via meat products.
- Streptogramin resistance (vatA, vatG) in E. faecium suggests an animal origin due to virginiamycin use.
Conclusions:
- The use of avoparcin as a feed additive created a significant reservoir of transferable glycopeptide resistance (vanA).
- The ban on avoparcin has correlated with a decrease in glycopeptide-resistant Enterococcus faecium (GREF) in both animal and human populations.
- Evidence supports the prohibition of antibacterial growth promoters that could compromise human antimicrobial chemotherapy.